We are live on ! Find out more
OPCH icon

Option Care Health

160 hedge funds and large institutions have $2.23B invested in Option Care Health in 2021 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 39 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,545% more call options, than puts

Call options by funds: $8.96M | Put options by funds: $545K

67% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 39

46% more capital invested

Capital invested by funds: $1.52B → $2.23B (+$706M)

17% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 30

10.22% more ownership

Funds ownership: 47.65%57.87% (+10%)

3% more funds holding

Funds holding: 155160 (+5)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

Holders
160
Holders Change
+5
Holders Change %
+3.23%
% of All Funds
2.79%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
35
Increased
65
Reduced
39
Closed
30
Calls
$8.96M
Puts
$545K
Net Calls
+$8.42M
Net Calls Change
+$5.21M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$15.8M +$2.72M +141,275 +24%
GF
27
Gabelli Funds
New York
$15.5M +$823K +42,712 +6%
SCA
28
STALEY CAPITAL ADVISERS
Pennsylvania
$14.8M
JP Morgan Chase
29
JP Morgan Chase
New York
$12.6M +$7.59M +393,769 +216%
PCM
30
Penn Capital Management
Pennsylvania
$11.2M +$505K +26,184 +5%
Deutsche Bank
31
Deutsche Bank
Germany
$10.8M +$315K +16,354 +3%
SCM
32
Sirios Capital Management
Massachusetts
$10.5M -$2.87M -149,000 -24%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$9.81M +$3.6M +186,845 +71%
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$8.71M +$7.67M +398,044 New
HighTower Advisors
35
HighTower Advisors
Illinois
$8.54M +$312K +16,177 +4%
RCW
36
Rheos Capital Works
Japan
$8.22M +$7.25M +376,000 New
Principal Financial Group
37
Principal Financial Group
Iowa
$7.66M +$5.61M +291,131 +493%
Millennium Management
38
Millennium Management
New York
$7.62M -$23.9M -1,237,562 -78%
Bank of America
39
Bank of America
North Carolina
$7.33M +$554K +28,719 +9%
LCG
40
Luxor Capital Group
New York
$7.27M +$6.41M +332,300 New
EP
41
Eversept Partners
New York
$6.33M +$5.58M +289,297 New
Point72 Asset Management
42
Point72 Asset Management
Connecticut
$6.12M +$5.4M +280,000 New
DADC
43
D.A. Davidson & Co
Montana
$5.61M +$658K +34,150 +15%
CHP
44
Castle Hook Partners
New York
$5.47M +$2.43M +126,092 +102%
First Trust Advisors
45
First Trust Advisors
Illinois
$5.11M -$9.89K -513 -0.2%
PCM
46
Pinz Capital Management
New York
$5.01M +$1.46M +75,550 +49%
Norges Bank
47
Norges Bank
Norway
$4.76M
Neuberger Berman Group
48
Neuberger Berman Group
New York
$4.6M -$2.7M -139,845 -40%
SCM
49
Segantii Capital Management
Hong Kong
$4.55M +$4.01M +208,000 New
VIA
50
Vantis Investment Advisers
Florida
$4.5M +$3.97M +205,900 New

OPCH Hedge Fund Activity: Q2 2021 in Review

160 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Option Care Health (OPCH) for Q2 2021, worth a combined $2.23B — up 46% from $1.52B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new OPCH positions and 30 closed out — a net gain of 5 holders — while 65 added to existing stakes and 39 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $114M. The largest seller was Luminus Management, exiting entirely with an estimated $27.3M sold.

  • 160 institutional investors held Option Care Health (OPCH) as of Q2 2021, up from 155 in Q1 2021.
  • Funds reported $2.23B of Option Care Health stock for Q2 2021, up 46% quarter-over-quarter.
  • 35 funds opened new Option Care Health positions in Q2 2021 and 30 closed out, a net change of +5 holders.
  • The largest Option Care Health buyer in Q2 2021 was Fidelity Investments, an estimated $114M added.
  • The largest Option Care Health seller in Q2 2021 was Luminus Management, an estimated $27.3M sold.

Based on aggregated 13F filings for Q2 2021.